// App-Quantinova.ai

TCTAP A-056 : Benefits of Percutaneous Atrial Septal Defect Occlusion in Patients Older than 60

Researchers

Presenter

  • Yam Hong Wong

Principal Investigators

  • N/A

Medical Centers

  • Queen Mary Hospital, Hong Kong, Hong Kong

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

  • Diastolic dysfunction

  • Atrial septal defect

  • Arrhythmia

  • Venous thrombosis

  • Congestive heart failure

  • Hypertension

Biomarkers

  • Carboxypeptidase B1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved